What is Difference Between Insulin and Glucagon? Peptide Product Comparison Guide
Abstract: Insulin and glucagon are critical peptide hormones with opposing metabolic roles. Insulin lowers blood glucose by promoting cellular uptake, while glucagon raises it via glycogenolysis. Market trends show rising demand for biosimilar insulins and stable glucagon for emergency hypoglycemia. Key brands (Novo Nordisk, Eli Lilly) dominate, with insulin offering advanced analog technologies (e.g., faster absorption) versus glucagon’s simpler stability profile. Product parameters differ in half-life (insulin: 4-6h; glucagon: 18-20min) and storage requirements. Industry growth is driven by diabetes prevalence and peptide delivery innovations. Selection criteria prioritize purity, regulatory certifications (FDA/EMA), and cold-chain logistics.